STORRS, CT (US), December 2019 — Osteogenesis imperfecta (OI) is a group of genetic disorders that mainly affect the bone. Patients with OI have bones that break easily, sometimes with no apparent cause.
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
OSAKA (JP), December 2019 — A group of researchers at Osaka University revealed that endothelial cell-selective adhesion molecule (ESAM), a surface marker for hematopoietic stem cells (HSCs) and vascular endothelial cells (ECs), played an important role in the ontogeny of hematop
HEIDELBERG (DE), December 2019 — Stem cells located in the bone marrow generate and control the production of blood and immune cells. Researchers have now developed new methods to reveal the three-dimensional organization of the bone marrow at the single cell level.
BALTIMORE, MD (US) December 2019 — The buildup of scar tissue makes recovery from torn rotator cuffs, jumper’s knee and other tendon injuries a painful, challenging process, often leading to secondary tendon ruptures.
HOUSTON, TX (US), December 2019 — A new study reveals a mechanism that contributes to adult bone maintenance and repair and opens the possibility of developing therapeutic strategies for improving bone healing.
ATLANTA, GA (US), December 2019 — Future cardiac outcomes can be predicted by signs of cardiac stress that appear in the blood in response to exercise, Emory cardiologists report.
The results were published recently in JAMA Cardiology.
RALEIGH, NC (US), December 2019 — In a new paper, researchers at North Carolina State University lift the veil on the "conductor" plant root stem cell gene that helps orchestrate and coordinate stem cell division of different root stem cell types, ensuring the harmonic communicat
WINSTON-SALEM, NC (US), December 2019 — Wake Forest Institute for Regenerative Medicine (WFIRM) scientists are the first to report using bioprinting to print a tracheal tissue construct comprised of multiple different functional materials.
ATLANTA, GA (US), December 2019 — Research on immune cells “exhausted” by chronic viral infection provides clues on how to refine cancer immunotherapy. The results were published recently in Immunity.
BOSTON, MA (US), December 2019 — For patients with high-risk myeloid cancers undergoing a donor stem cell transplant, adding the targeted drug venetoclax to a reduced-intensity drug regimen prior to transplant is safe and does not impair the ability of the donor cells to take roo